2.10. In Vivo Bioluminescence Imaging and Quantification of Tumor Burden.

CC Christine P. Carney
AK Anshika Kapur
PA Pavlos Anastasiadis
RR Rodney M. Ritzel
CC Chixiang Chen
GW Graeme F. Woodworth
JW Jeffrey A. Winkles
AK Anthony J. Kim
ask Ask a question
Favorite

Intracranial tumor growth was monitored via bioluminescence imaging. Briefly, animals were anesthetized in an induction chamber with 2.5% isoflurane and intraperitoneally injected with Pierce D-Luciferin (150 mg/kg, dissolved in PBS) (ThermoFisher Cat# 88293). After 10 min, animals were moved to a Xenogen IVIS system (Caliper Life Sciences, Hopkinton, MA) maintained at 2.5% isoflurane and imaged for tumor bioluminescence. Photons emitted from live mice were acquired as photons/s/cm2/steradian (p/s/cm2/sr). The average radiance (p/s/cm2/sr) within identical regions of interest drawn around the brain was used to quantify tumor burden using Living Image software (PerkinElmer, MA).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A